Mr Mrs Miss Ms Dr Other

Mrs
Ellie
Purnell

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.

Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

(Cantab) Natural Sciences - Double First Class Honours

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction

Recognition

Senior Scholar and Honarary Senior Scholar of Gonville & Caius College, Cambridge

Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010

The Frank Smart Prize for Botany

Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010

The Keith Farewell Prize

Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)

Publications

First CRISPR therapy approved for use in the UK

View publication online

CRISPR Edited T cells win the TvT Battle

View publication online

Patenting antibodies in the US and Europe

View publication online

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

AI solution to Levinthal's paradox

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

A look at the WIPO coronavirus tools

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

G3/19: An end to the saga…

View publication online

G3/19: A further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

G3/19: A Further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

A look at the WIPO coronavirus tools

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

How a platform technology patent list can expedite covid-19 vaccine research

View publication online

The Patent Landscape Behind COVID-19 Vaccines

View publication online

Conferences: 2022

September 22nd 2022

BioCap Conference 2022

Attended

Event details

Conferences: 2021

July 2nd 2021

G1/21 hearing at the EPO - July

Attended

Event details

January 7th 2021

iBioIC

Attended

Event details

Conferences: 2020

November 4th 2020

Bionow Oncology Conference 2020

Attended

Event details

CSR

Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.

She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).

In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.

Related News

EPO Annual Fee Increases

The European Patent Office (EPO) has announced that revised Official Fees will apply to payments made on or after Monday 1st April 2024. The majority of fees will increase by …

Read article
Event - 30th January 2024

CAR-TCR Summit, Europe 2024

HGF are proud Event Partners of CAR-TCR Europe, which is due to go ahead from 27th – 29th February at ExCeL, Royal Victoria Dock in London. This is the European hub …

Event details

How to Use IP Strategy to Tip the Odds in Your Favour

Porter’s Five Forces model [1] is just one example of a convenient model for exploring and understanding the forces at play in a competitive marketplace. Michael Porter’s Five Forces model …

Read article

First CRISPR therapy approved for use in the UK

In an unprecedented move, the MHRA has approved a CRISPR gene editing therapy ‘Casgevy’  for the treatment of sickle cell disease and beta-thalassaemia in patients with recurrent vaso-occlusive crises. The Casgevy …

Read article
Event - 8th, 22nd February 2024

Dresden & Salzburg Seminar: Invention and patent searches in public databases

HGF is pleased to invite you to our upcoming German-language seminar on “Invention and patent searches in public databases” in Salzburg and Dresden. The seminar will showcase how public databases …

Event details
Event - 29th November 2023

HGF & Shiga Webinar Recording: Medical devices and bioinformatics / AI diagnostic feedback - law and practice in Europe and Japan

“Medical devices and bioinformatics / AI diagnostic feedback – law and practice in Europe and Japan” The EPC does not allow ‘medical use’ claims for medial devices. So how do …

Event details

Blog Series: IP Ingredients, Part 1: Can you patent a recipe?

A patent is a legal right that enables the patent holder to prevent others from making and using their invention in the country where the patent is granted.  To many …

Read article

UPC and Forum Shopping – Rule 17.3

Order of the classifications listed on the front of a patent and why it matters? On 1 June 2023, ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE lodged a statement of revocation of …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.